All Stories

  1. Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases

    Article • Cancer Management and Research, November 2019, Taylor & Francis

    Dr Wang Jing

  2. Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study

    Article • OncoTargets and Therapy, October 2019, Taylor & Francis

    Dr Wang Jing

  3. Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report

    Article • OncoTargets and Therapy, September 2019, Taylor & Francis

    Dr Wang Jing

  4. Slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma

    Article • Cancer Biology & Therapy, April 2019, Taylor & Francis

    Dr Wang Jing

  5. Clinical value of carcinoembryonic antigen for predicting the incidence of brain metastases and survival in small cell lung cancer patients treated with prophylactic cranial irradiation

    Article • Cancer Management and Research, September 2018, Dove Medical Press

    Dr Wang Jing

  6. Great efficacy of bevacizumab plus erlotinib for leptomeningeal metastases from non-small cell lung cancer with initially positive EGFR mutation: a case report

    Article • Cancer Biology & Therapy, August 2018, Taylor & Francis

    Dr Wang Jing

  7. The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma

    Article • OncoTargets and Therapy, May 2017, Dove Medical Press

    Dr Wang Jing

  8. PD-1/PD-L1 in NSCLC

    Article • OncoTargets and Therapy, January 2016, Dove Medical Press

    Dr Wang Jing